BioCleanse Tissue Sterilization Process (Prod 5850)

About BioCleanse Tissue Sterilization Process (Prod 5850)

As awareness of the benefits of human donor (allograft) tissue increases, more surgeons and patients elect to use it in surgery; allograft is used in more than 600,000 surgical procedures in the United States every year. Unless tissue is sterilized through an effective process, however, there is a risk of disease transmission. Allograft safety can be improved by using validated, low temperature chemical sterilization technologies that kill the most resistant organisms (such as non-enveloped viruses and spores) but preserve the biomechanical integrity and function of allografts. The BioCleanse™ Tissue Sterilization Process addresses this through its sterilization and viral inactivation process that does not alter the beneficial properties of tissue, allowing for the more consistent processing of allografts. The BioCleanse™ process sets a new standard for tissue safety. It has been validated to eliminate HIV, hepatitis, bacteria, fungi and spores, and remove 99.9% of blood, lipids and marrow.

Request Product Information

Disclaimer: is a list of products and services. Every effort is made to keep this listing as accurate and current as possible. Companies and individuals are encouraged to notify us of errors and omissions. We will respond to such messages of correction in a timely fashion, as our workload permits.

We are non-judgmental of products listed. We are not in the business of evaluating products. We have not evaluated these products. We make no representations as to the quality, effectiveness, suitability or appropriateness of any of the products listed.

As an important component of the service function of, some products continue to be listed that are no longer manufactured and may not be available. We will identify them as such when possible. This allows users to find special instruments and/or components for removal, modification, and/or revision of those products.